Flora Growth Enters Into Definitive Agreement To Acquire TruHC In Exchange For 2,770,562 Flora Common Shares Valued At $6.4M
Flora Growth Enters Into Definitive Agreement To Acquire TruHC In Exchange For 2,770,562 Flora Common Shares Valued At $6.4M
Flora Growth签订收购TruHC的最终协议，以换取价值640万美元的2770,562股Flora普通股
- Acquisition capitalizes on TruHC's strategically built German cannabis platform, including:
- EU-GMP processing and production license
- GDP wholesale license for import / export
- EU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensaries
- Narcotics license with EU-GMP certified storage
- EU-GMP certified laboratory for instant cannabis analysis
- Transaction combines Flora's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team with extensive experience building successful medical and recreational cannabis companies across Germany, Canada, and the United States.
- Germany poised to become world's largest federally legal cannabis market with expected market potential of over $10 billion with federal legalization and the critical elimination of banking, financial, capital markets, and tax constraints faced by U.S. operators.
- 此次收购利用了TruHC战略建立的德国大麻平台，包括：
- EU-GMP 加工和生产许可证
- GDP 进出口批发许可证
- 经欧盟GMP认证的可定制模块，可灵活地整合各种生产/包装流程，并且可以延长该国未来种植和向大麻药房供应的许可证
- 带有欧盟 GMP 认证存储空间的麻醉品许可证
- 经欧盟GMP认证的即时大麻分析实验室
- 该交易将Flora广泛的全球CPG和药品分销网络与TruHC深厚的全球大麻专业知识相结合，其中包括一支在德国、加拿大和美国建立成功的医疗和休闲大麻公司具有丰富经验的高管团队。
- 随着联邦合法化以及美国运营商面临的银行、金融、资本市场和税收限制的关键消除，德国有望成为世界上最大的联邦合法大麻市场，其市场潜力预计将超过100亿美元。